← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Gelsana Therapeutics, Inc.
Aurora, CO
$624,642
Total funding
2
Grants
Funding over time
peak $325K · FY2023–24$500K$375K$250K$125K$0
'23
'24
Funding mix
By agency
NIH$624,642 · 2
By mechanism
R43$624,642 · 2
Investigators at Gelsana Therapeutics, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Advancing Diabetic Foot Ulcer Treatment with Provasliex, a Controlled PDGF Release Hydrogel for Promoting Vascularization and Managing Overactive Inflammation$324,992
R43 · FY2024 · DK
Topical Drug Delivery System as an Anti-Inflammatory and Pro-Angiogenic Therapy for Diabetic Wound Healing$299,650
R43 · FY2023 · DK